Submitting OIG:
Report Description:
On March 13, 2020, the President of
the United States declared that the
COVID-19 pandemic was a national
emergency. That same day, in
accordance with section 1135(b) of
the Social Security Act (the Act), the
Secretary of HHS invoked his
authority to waive or modify certain
requirements of Titles XVIII, XIX, and
XXI of the Act.
To limit the spread of the virus,
Federal, State and local governments
urged individuals to stay at home and
for individuals who test positive to
quarantine, among other preventive
measures. As a result, the usual and
customary ways that many
individuals obtained prescription
drugs were altered and access to
those prescription drugs reduced.
Our objective was to identify actions
that selected States took or planned
to take to ensure that Medicaid
beneficiaries continued to receive
prescription drugs during the COVID-
19 pandemic.
Date Issued:
Wednesday, October 13, 2021
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-06-20-04007
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Audit
Special Projects:
Questioned Costs:
$0
Funds for Better Use:
$0
Additional Details Link: